FDA Approves Revolutionary Gene Therapy for Rare Neuromuscular Disease, Achieving 80% Efficacy in Halting Progression
FDA fast-tracks gene therapy for rare neuromuscular disorder XLMTM, with 80% efficacy…
Search
Have an existing account?
Sign In
Tag: XLMTM
